Literature DB >> 12396006

Assays for the functional activity of the mannan-binding lectin pathway of complement activation.

Steffen Thiel1, Mette Møller-Kristensen, Lisbeth Jensen, Jens C Jensenius.   

Abstract

Mannan-binding lectin (MBL) activates complement independently of the adaptive, clonal immune system and thus presents an innate anti-microbial defence mechanism. Events in the MBL pathway of complement activation involve the binding of MBL to patterns of carbohydrate structures presented by the surface of micro-organisms. For the activation of complement to occur MBL must be associated with serine proteases (MBL-associated serine proteases, MASPs) in an MBL/MASP complex. When bound to micro-organisms, the MBL complex mediates the activation of C4 and C2, generating the C3 convertase, C4bC2b. The C4/C2 cleaving activity of the MBL complex is shared with the C1 complex of the classical pathway of complement activation. Different assays that allow for determination of the activity of the MBL complex in serum samples have been developed and are discussed in this report. We present data from one such assay (MBL/MASP activity test), which we have found useful for the routine evaluation of clinical samples. In this assay any influence of the classical pathway has been eliminated by using a hypertonic buffer, which inhibits the binding of C1q to immuncomplexes and disrupt the C1 complex, while leaving the function of the MBL complex intact. In parallel we determine the MBL concentration in the sample. As predicted a very high correlation is observed between the results of the two assays.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12396006     DOI: 10.1078/0171-2985-00145

Source DB:  PubMed          Journal:  Immunobiology        ISSN: 0171-2985            Impact factor:   3.144


  36 in total

1.  Influence of major surgery on the mannan-binding lectin pathway of innate immunity.

Authors:  H Ytting; I J Christensen; L Basse; J Lykke; S Thiel; J C Jensenius; H J Nielsen
Journal:  Clin Exp Immunol       Date:  2006-05       Impact factor: 4.330

2.  Reciprocal antibody and complement responses of two chicken breeds to vaccine strains of Newcastle disease virus, infectious bursal disease virus and infectious bronchitis virus.

Authors:  R Baelmans; H K Parmentier; P Dorny; F Demey; D Berkvens
Journal:  Vet Res Commun       Date:  2006-07       Impact factor: 2.459

3.  Increased levels of mannan-binding lectin in type 1 diabetic patients with incipient and overt nephropathy.

Authors:  M Saraheimo; C Forsblom; T K Hansen; A-M Teppo; J Fagerudd; K Pettersson-Fernholm; S Thiel; L Tarnow; P Ebeling; A Flyvbjerg; P-H Groop
Journal:  Diabetologia       Date:  2004-12-23       Impact factor: 10.122

4.  Collectin liver 1 and collectin kidney 1 and other complement-associated pattern recognition molecules in systemic lupus erythematosus.

Authors:  A Troldborg; S Thiel; L Jensen; S Hansen; M J Laska; B Deleuran; J C Jensenius; K Stengaard-Pedersen
Journal:  Clin Exp Immunol       Date:  2015-08-31       Impact factor: 4.330

5.  Design of a complement mannose-binding lectin pathway-specific activation system applicable at low serum dilutions.

Authors:  M Harboe; P Garred; M S Borgen; G L Stahl; A Roos; T E Mollnes
Journal:  Clin Exp Immunol       Date:  2006-06       Impact factor: 4.330

6.  Ficolin-1 Levels in Patients Developing Vasospasm and Cerebral Ischemia After Spontaneous Subarachnoid Hemorrhage.

Authors:  Laura Llull; Steffen Thiel; Sergio Amaro; Álvaro Cervera; Anna M Planas; Ángel Chamorro
Journal:  Mol Neurobiol       Date:  2016-10-12       Impact factor: 5.590

7.  Lectin complement pathway proteins in healthy individuals.

Authors:  A Troldborg; A Hansen; S W K Hansen; J C Jensenius; K Stengaard-Pedersen; S Thiel
Journal:  Clin Exp Immunol       Date:  2017-01-18       Impact factor: 4.330

8.  Pattern Recognition Molecules of the Lectin Pathway-Screening of Patients with Suspected Immunodeficiency.

Authors:  Clara Mistegård Jørgensen; Lisbeth Jensen; Mette Christiansen; Mette Bjerre; Jens Magnus Bernth Jensen; Steffen Thiel
Journal:  J Clin Immunol       Date:  2019-08-03       Impact factor: 8.317

9.  Genetically-defined deficiency of mannose-binding lectin is associated with protection after experimental stroke in mice and outcome in human stroke.

Authors:  Alvaro Cervera; Anna M Planas; Carles Justicia; Xabier Urra; Jens C Jensenius; Ferran Torres; Francisco Lozano; Angel Chamorro
Journal:  PLoS One       Date:  2010-02-03       Impact factor: 3.240

10.  Mannose-binding lectin genotype and phenotype in patients with type 2 diabetes and myocardial infarction: a report from the DIGAMI 2 trial.

Authors:  L G Mellbin; A Hamsten; K Malmberg; R Steffensen; L Rydén; J Ohrvik; T K Hansen
Journal:  Diabetes Care       Date:  2010-08-06       Impact factor: 17.152

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.